{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:24:16Z","timestamp":1762143856340},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2002,6,1]],"date-time":"2002-06-01T00:00:00Z","timestamp":1022889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2002,6]]},"DOI":"10.1067\/mjd.2002.120472","type":"journal-article","created":{"date-parts":[[2002,8,24]],"date-time":"2002-08-24T22:14:26Z","timestamp":1030227266000},"page":"886-891","source":"Crossref","is-referenced-by-count":82,"title":["Treatment of psoriasis with the chimeric monoclonal antibody against tumor necrosis factor \u03b1, infliximab"],"prefix":"10.1067","volume":"46","author":[{"given":"Rudolf E.","family":"Schopf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger","family":"Aust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Knop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1067\/mjd.2002.120472_bib1","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/0161-5890(93)90106-L","article-title":"Construction and initial characterization of a mouse-human chimeric anti-TNF antibody","volume":"30","author":"Knight","year":"1993","journal-title":"Mol Immunol"},{"key":"10.1067\/mjd.2002.120472_bib2","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1067\/mjd.2000.105948","article-title":"Treatment with anti-tumor necrosis factor alpha (TNF-alpha) monoclonal antibody dramatically decreases the clinical activity of psoriasis lesions","volume":"42","author":"Oh","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2002.120472_bib3","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1365-2133.2001.04089.x","article-title":"Treatment of psoriatic arthritis with anti-tumour necrosis factor-alpha antibody clears skin lesions of psoriasis resistant to treatment with methotrexate","volume":"144","author":"Ogilvie","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2002.120472_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1365-2230.2001.00753.x","article-title":"Successful treatment of severe recalcitrant psoriasis with combination infliximab and methotrexate","volume":"26","author":"Kirby","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"10.1067\/mjd.2002.120472_bib5","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJM197909063011015","article-title":"Cyclosporin A for psoriasis","volume":"301","author":"M\u00fcller","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1067\/mjd.2002.120472_bib6","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nm0595-442","article-title":"Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis","volume":"1","author":"Gottlieb","year":"1995","journal-title":"Nat Med"},{"key":"10.1067\/mjd.2002.120472_bib7","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1365-2249.1994.tb06244.x","article-title":"Elevated tumor necrosis factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions","volume":"96","author":"Ettehadi","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1067\/mjd.2002.120472_bib8","first-page":"129","article-title":"Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis","volume":"138","author":"Nickoloff","year":"1991","journal-title":"Am J Pathol"},{"key":"10.1067\/mjd.2002.120472_bib9","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s004030050299","article-title":"An important role of tumor necrosis factor-alpha in the induction of adhesion molecules in psoriasis","volume":"290","author":"Terajima","year":"1998","journal-title":"Arch Dermatol Res"},{"key":"10.1067\/mjd.2002.120472_bib10","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1084\/jem.178.3.1067","article-title":"Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte conditioned medium","volume":"178","author":"O'Dougherty","year":"1993","journal-title":"J Exp Med"},{"key":"10.1067\/mjd.2002.120472_bib11","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000250839","article-title":"Severe psoriasis\u2014oral therapy with a new retinoid","volume":"157","author":"Fredriksson","year":"1978","journal-title":"Dermatologica"},{"key":"10.1067\/mjd.2002.120472_bib12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF00375799","article-title":"Etretinate or cyclosporin-A treatment normalizes the enhanced respiratory burst of polymorphonuclear leukocytes in psoriasis","volume":"284","author":"Schopf","year":"1992","journal-title":"Arch Dermatol Res"},{"key":"10.1067\/mjd.2002.120472_bib13","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/S0140-6736(00)04954-0","article-title":"Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomized trial","volume":"357","author":"Chaudhari","year":"2001","journal-title":"Lancet"},{"key":"10.1067\/mjd.2002.120472_bib14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2133.1988.tb03204.x","article-title":"Improvement of psoriasis by topical vitamin D3 analogue (MC 903) in a double-blind study","volume":"119","author":"Kragballe","year":"1988","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2002.120472_bib15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF00417528","article-title":"Stimulation of T cells by autologous mononuclear leukocytes and epidermal cells in psoriasis","volume":"279","author":"Schopf","year":"1986","journal-title":"Arch Dermatol Res"},{"key":"10.1067\/mjd.2002.120472_bib16","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0190-9622(91)70102-8","article-title":"Tumor necrosis factor","volume":"24","author":"Wakefield","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2002.120472_bib17","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/978-1-4615-1971-3_121","article-title":"Importance of HLA-DR+ and CD1a+ epidermal cells for cytokine production in psoriasis","volume":"378","author":"Dobmeyer","year":"1995","journal-title":"Adv Exp Med Biol"},{"key":"10.1067\/mjd.2002.120472_bib18","first-page":"149","article-title":"Cytokines","author":"Oppenheim","year":"1999"},{"issue":"Suppl 6","key":"10.1067\/mjd.2002.120472_bib19","doi-asserted-by":"crossref","first-page":"216S","DOI":"10.1111\/1523-1747.ep12875802","article-title":"TNF alpha primes polymorphonuclear leukocytes for an enhanced respiratory burst to a similar extent as bacterial lipopolysaccharide","volume":"95","author":"Schopf","year":"1990","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2002.120472_bib20","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/BF00371816","article-title":"Effect of tumor necrosis factor alpha in vivo on human granulocyte oxidative metabolism","volume":"283","author":"Kapp","year":"1991","journal-title":"Arch Dermatol Res"},{"key":"10.1067\/mjd.2002.120472_bib21","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/1523-1747.ep12337469","article-title":"A TNF-alpha promoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis","volume":"109","author":"Hohler","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2002.120472_bib22","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(00)02530-7","article-title":"Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomized trial","volume":"356","author":"Mease","year":"2000","journal-title":"Lancet"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962202000099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962202000099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T10:28:40Z","timestamp":1557397720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962202000099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2002,6]]}},"alternative-id":["S0190962202000099"],"URL":"https:\/\/doi.org\/10.1067\/mjd.2002.120472","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2002,6]]}}}